Zimmer Biomet Doubling Down on Innovation During COVID

Zimmer Biomet reported 1Q20 orthopedic revenue of USD $1,602.4 million, -9.2% vs. 1Q19. Procedure and capital purchase deferrals due to COVID-19 significantly impacted the company’s results, with revenue down -60% in the last two weeks of March. ROSA contributed little to sales in the quarter, as system sales are generally weighted heavily...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us